{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35145311",
  "DateCompleted": {
    "Year": "2022",
    "Month": "04",
    "Day": "21"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "06"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "02",
        "Day": "10"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1038/s41591-022-01679-5"
    ],
    "Journal": {
      "ISSN": "1546-170X",
      "JournalIssue": {
        "Volume": "28",
        "Issue": "4",
        "PubDate": {
          "Year": "2022",
          "Month": "Apr"
        }
      },
      "Title": "Nature medicine",
      "ISOAbbreviation": "Nat Med"
    },
    "ArticleTitle": "Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial.",
    "Pagination": {
      "StartPage": "823",
      "EndPage": "830",
      "MedlinePgn": "823-830"
    },
    "Abstract": {
      "AbstractText": [
        "The mRNA-1273 vaccine for coronavirus disease 2019 (COVID-19) demonstrated 93.2% efficacy in reduction of symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in the blinded portion of the Phase\u20093 Coronavirus Efficacy (COVE) trial. While mRNA-1273 demonstrated high efficacy in prevention of COVID-19, including severe disease, its effect on the viral dynamics of SARS-CoV-2 infections is not understood. Here, in exploratory analyses, we assessed the impact of mRNA-1273 vaccination in the ongoing COVE trial (number NCT04470427) on SARS-CoV-2 copy number and shedding, burden of disease and infection, and viral variants. Viral variants were sequenced in all COVID-19 and adjudicated COVID-19 cases (n\u2009=\u2009832), from July 2020 in the blinded part\u2009A of the study to May 2021 of the open-label part B of the study, in which participants in the placebo arm started to receive the mRNA-1273 vaccine after US Food and Drug Administration emergency use authorization of mRNA-1273 in December 2020. mRNA-1273 vaccination significantly reduced SARS-CoV-2 viral copy number (95% confidence interval) by 100-fold on the day of diagnosis compared with placebo (4.1 (3.4-4.8) versus 6.2 (6.0-6.4) log<sub>10</sub> copies per\u2009ml). Median times to undetectable viral copies were 4\u2009days for mRNA-1273 and 7\u2009days for placebo. Vaccination also substantially reduced the burden of disease and infection scores. Vaccine efficacies (95% confidence interval) against SARS-CoV-2 variants circulating in the United States during the trial assessed in this post hoc analysis were 82.4% (40.4-94.8%) for variants Epsilon and Gamma and 81.2% (36.1-94.5%) for Epsilon. The detection of other, non-SARS-CoV-2, respiratory viruses during the trial was similar between groups. While additional study is needed, these data show that in SARS-CoV-2-infected individuals, vaccination reduced both the viral copy number and duration of detectable viral RNA, which may be markers for the risk of virus transmission."
      ],
      "CopyrightInformation": "\u00a9 2022. The Author(s)."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-5155-5079"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Moderna, Inc., Cambridge, MA, USA. rolando.pajon@modernatx.com."
          }
        ],
        "LastName": "Pajon",
        "ForeName": "Rolando",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Moderna, Inc., Cambridge, MA, USA."
          }
        ],
        "LastName": "Paila",
        "ForeName": "Yamuna D",
        "Initials": "YD"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Moderna, Inc., Cambridge, MA, USA."
          }
        ],
        "LastName": "Girard",
        "ForeName": "Bethany",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Moderna, Inc., Cambridge, MA, USA."
          }
        ],
        "LastName": "Dixon",
        "ForeName": "Groves",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Moderna, Inc., Cambridge, MA, USA."
          }
        ],
        "LastName": "Kacena",
        "ForeName": "Katherine",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Brigham and Women's Hospital, Boston, MA, USA."
          }
        ],
        "LastName": "Baden",
        "ForeName": "Lindsey R",
        "Initials": "LR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Baylor College of Medicine, Houston, TX, USA."
          }
        ],
        "LastName": "El Sahly",
        "ForeName": "Hana M",
        "Initials": "HM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Meridian Clinical Research, Omaha, NE, USA."
          }
        ],
        "LastName": "Essink",
        "ForeName": "Brandon",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University of Chicago, Chicago, IL, USA."
          }
        ],
        "LastName": "Mullane",
        "ForeName": "Kathleen M",
        "Initials": "KM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University of Pennsylvania, Philadelphia, PA, USA."
          }
        ],
        "LastName": "Frank",
        "ForeName": "Ian",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Clinical Trials of Texas, San Antonio, TX, USA."
          }
        ],
        "LastName": "Denhan",
        "ForeName": "Douglas",
        "Initials": "D"
      },
      {
        "Identifier": [
          "0000-0002-1697-9036"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Criscor Clinical Research Institute, Medford, OR, USA."
          }
        ],
        "LastName": "Kerwin",
        "ForeName": "Edward",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Moderna, Inc., Cambridge, MA, USA."
          }
        ],
        "LastName": "Zhao",
        "ForeName": "Xiaoping",
        "Initials": "X"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Moderna, Inc., Cambridge, MA, USA."
          }
        ],
        "LastName": "Ding",
        "ForeName": "Baoyu",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Moderna, Inc., Cambridge, MA, USA."
          }
        ],
        "LastName": "Deng",
        "ForeName": "Weiping",
        "Initials": "W"
      },
      {
        "Identifier": [
          "0000-0002-9399-2867"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Moderna, Inc., Cambridge, MA, USA."
          }
        ],
        "LastName": "Tomassini",
        "ForeName": "Joanne E",
        "Initials": "JE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Moderna, Inc., Cambridge, MA, USA."
          }
        ],
        "LastName": "Zhou",
        "ForeName": "Honghong",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Moderna, Inc., Cambridge, MA, USA."
          }
        ],
        "LastName": "Leav",
        "ForeName": "Brett",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Moderna, Inc., Cambridge, MA, USA."
          }
        ],
        "LastName": "Sch\u00f6del",
        "ForeName": "Florian",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "CollectiveName": "COVE Trial Consortium"
      }
    ],
    "DataBankList": [
      {
        "DataBankName": "ClinicalTrials.gov",
        "AccessionNumberList": [
          "NCT04470427"
        ]
      }
    ],
    "GrantList": [
      {
        "GrantID": "UM1 AI148575",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "UM1 AI069534",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "UM1 AI068614",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "UM1 AI068618",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "UM1 AI148684",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "UM1 AI068635",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "UM1 AI068619",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "UM1 AI068636",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "P30 AI045008",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "UM1 AI069412",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial, Phase III",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Nat Med",
    "NlmUniqueID": "9502015",
    "ISSNLinking": "1078-8956"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "EPK39PL4R4",
      "NameOfSubstance": "2019-nCoV Vaccine mRNA-1273"
    }
  ],
  "SupplMeshList": [
    "SARS-CoV-2 variants"
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "2019-nCoV Vaccine mRNA-1273"
    },
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "United States"
    }
  ]
}